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C-type lectin receptors (CLRs) comprise a heterogeneous group of transmembrane proteins. Many of them
are expressed in myeloid cells and signal in response to pathogen-derived or self ligands to initiate or regu-
late cell activation. Here, we review the properties of myeloid CLRs, highlighting how their signaling function
is coordinated with that of other innate receptor families to control immunity to infection.Introduction
The term ‘‘C-type lectin’’ was first used to differentiate a group of
Ca2+-dependent carbohydrate-binding (lectin) proteins from the
rest of the animal lectins (Zelensky and Gready, 2005). The
carbohydrate binding properties of C-type lectins were found
to reside within a compact protein region with a unique structural
fold that became known as the ‘‘C-type carbohydrate recogni-
tion domain (CRD)’’ or ‘‘C-type lectin domain’’ (Weis and Drick-
amer, 1996). Sequence homology led to the identification of
C-type CRDs in many additional proteins, including ones that
did not bind to carbohydrates or calcium. This contradiction
was resolved by introducing a more general term, ‘‘C-type lec-
tin-like domain’’ (CTLD) to refer to the fold (Zelensky and Gready,
2005). The CTLD is now considered a structural motif in protein
databases and the term ‘‘C-type lectin’’ is consequently used for
any protein possessing one or more CTLDs, independently of
carbohydrate or calcium binding ability. Analogous to the immu-
noglobulin superfamily, the C-type lectin family of proteins
therefore encompasses upwards of 1000 members with diverse
functions including cell adhesion, regulation of natural killer
function, complement activation, tissue remodeling, platelet
activation, endocytosis, phagocytosis, and innate immunity
(Weis and Drickamer, 1996; Zelensky and Gready, 2005).
Microbial and viral signatures or ‘‘pathogen-associated
molecular patterns’’ (PAMPs) are often made up of carbohy-
drates. Glucans are prominent constituents of the cell walls of
fungi, plants, and mycobacteria; high-mannose structures are
expressed by some viruses, fungi, and bacteria; and fucose
structures are found on the surface of helminths and some
bacteria (Geijtenbeek and Gringhuis, 2009; Robinson et al.,
2006). Not surprisingly, many C-type lectins that recognize
glycans, as well as others that do not bind carbohydrates,
have been shown to bind pathogens and to play a role in host
defense. Included in this group are soluble defensins such as
RegIIIg, which is produced in the gut and has direct microbicidal
activity (Cash et al., 2006), as well as collectins such asmannose
binding protein, which activates the complement cascade upon
binding to bacterial surfaces (Takahashi et al., 2006). A few
CTLD-bearing transmembrane proteins, here designated as
‘‘C-type lectin receptors’’ (CLRs), also recognize pathogens
and in some cases engage signaling pathways that propagate
into the cell to elicit microbicidal or inflammatory responses.These CLRs are prominently expressed on myeloid cells where
they perform multiple functions. Some effectively function as
pattern recognition receptors (PRRs) to initiate innate and adap-
tive immunity to infection. Others dampen or alter myeloid cell
activation andmodulate immune responses. This review focuses
on CLRs that signal in myeloid cells to initiate or tune immunity to
pathogens. This subset of C-type lectins cuts across existing
classifications based on CTLD sequence and domain organiza-
tion and is therefore discussed here on the basis of signaling
properties (Figure 1; Table 1).
CLR Signaling
Mannose receptor, DEC-205, and Langerin were among the first
CLRs shown to bind bacteria, fungi, and viruses (Table 1). These
CLRs have endocytic activity, mediate internalization of their
ligands, and can direct cargo into intracellular compartments
that allow for antigen processing and presentation. Such proper-
ties make these CLRs interesting candidates for antigen delivery
to dendritic cells (DCs) in immunotherapy (Caminschi et al.,
2009). However, there is limited evidence to date that signals
from these receptors alone are sufficient to elicit microbicidal
effector functions in myeloid cells or, importantly, for inducing
the gene transcription modules that are characteristic of innate
immunity to infection. In contrast, akin to the members of the
Toll-like receptor (TLR) family, other CLRs have been shown to
directly and autonomously couple PAMP recognition to myeloid
cell activation and, further downstream, to adaptive immunity.
Yet other myeloid CLRs do not act as ‘‘self-sufficient’’ PRRs
but do recognize PAMPs and modulate cell activation. The key
to understanding myeloid CLRs is therefore to examine the
signaling pathways that underlie their different functions
(Figure 1; Table 1).
CLRs that Signal via Tyrosine-Based Motifs
The few CLRs that to date have been shown to act as ‘‘self-suffi-
cient’’ PRRs utilize spleen tyrosine kinase (Syk) as their proximal
adaptor (Kerrigan and Brown, 2010; Robinson et al., 2006).
Syk normally binds to proteins containing immunoreceptor
tyrosine-based activation motifs (ITAM; Yxx(L/I)x6-12Yxx(L/I),
where the slashes indicate alternative amino acid residues).
Phosphorylation of the two tyrosines located within the motif
by kinases of the Src family creates a docking site for the tandemImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 651
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Figure 1. Classification of CLRs by Tyrosine-Based Signaling Motifs
The CLRs listed in Table 1 are schematically represented here. As in Table 1,
signaling motif refers to the potential to engage pathways that induce or
modulate gene expression rather than signal for endocytosis. Note that the
CLRs bearing a hemITAM or ITIMmotif are all type II transmembrane proteins;
hence the motif is written with the tyrosine depicted as membrane distal. The
ITIM motif sequence shown is compiled from that found in MICL and DCIR.
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change that leads to Syk activation and phosphorylation of
a variety of substrates (including Syk itself), initiating a signaling
cascade (Mo´csai et al., 2010). CLRs that couple to Syk often
do so by associating in trans with ITAM-bearing adaptors
(Figure 1; Table 1). However, a small group of CLRs has been
shown to bind Syk directly, through a single tyrosine-basedmotif
in the intracellular domain, termed hemITAM (Figure 1; Table 1).
Finally, a separate subgroup of CLRs antagonizes Syk activity by
means of immunoreceptor tyrosine-based inhibitory motifs
(ITIM; S/I/V/LxYxxI/V/L, where the slashes indicate alternative
amino acid residues), single tyrosine motifs analogous to hemI-
TAMs that recruit the phosphatases SHP-1, SHP-2, and SHIP
rather than kinases (Figure 1; Table 1). ITAM, hemITAM, and
ITIM signaling by CLRs is discussed below. Many CLRs also
use tyrosine-based motifs to signal for endocytosis and to
regulate antigen processing, but that aspect of signaling is not
covered in this review.
HemITAM Signaling
The first example of a Syk-coupled myeloid CLR was Dectin-1
(‘‘DC-associated C-type lectin 1’’; Table 1). Dectin-1 is a type II
transmembrane CLR that contains a single extracellular CTLD
and is classified structurally in the same CLR subgroup as the
NK cell receptors (Brown, 2006). However, it is not expressed
by NK cells but by DCs and other myeloid cell types, including
monocytes, macrophages, and neutrophils, as well as a subset
of gd T cells (Martin et al., 2009; Taylor et al., 2002). Cell surface
expression is stabilized by interaction with the CD37 tetraspanin
(Meyer-Wentrup et al., 2007). Dectin-1 recognizes b-1,3-linked
glucans prominent in the cell wall of fungi, some bacteria, and
plants (Palma et al., 2006) and binds to zymosan (a crude
preparation of baker’s yeast cell walls), to fungal pathogens,
including Candida spp., Aspergillus spp., Coccidiodes spp.,652 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.and Pneumocystis spp., and to bacterial pathogens such as
Mycobacteria (Table 1; Brown, 2006; Rothfuchs et al., 2007).
Notably, Dectin-1 does not have a typical CRD and binding to
b-glucans is calcium independent (Brown, 2006). In addition to
b-1,3-linked glucans, Dectin-1 is reported to possess an uniden-
tified endogenous ligand in T cells (Ariizumi et al., 2000b).
Although the intracellular domain ofDectin-1 contains adouble
tyrosine ITAM-like motif, the amino terminal tyrosine (Tyr3) of
Dectin-1 is not located within the appropriate YxxL context
(Ariizumi et al., 2000b). Nevertheless, the ITAM-like motif is
able to directly recruit and activate Syk upon Dectin-1 binding
to agonist ligands (Rogers et al., 2005; Underhill et al., 2005).
Notably, Tyr3 is dispensable and single phosphorylation of the
membrane-proximal tyrosine 15 is necessary and sufficient to
mediate signaling via Syk (Rogers et al., 2005). The single YxxL
motif responsible for this unusual mode of Syk activation was
therefore termed ‘‘hemITAM’’ to reflect the fact that it resembled
half (hemi-) of an ITAM (Robinson et al., 2006; Rogers et al.,
2005). An attractive hypothesis is that ligand-induced dimeriza-
tion of two Dectin-1 molecules allows two hemITAMs to come
together, thereby providing in trans a docking site for the two
SH2 domains of Syk (Figure 2). Data supporting a dimerization
model for signal initiation have been obtained for the related
CLR, CLEC-2 (Hughes et al., 2010). Sustained receptor signaling
may subsequently require large-scale exclusion of tyrosine
phosphatases from the area of Dectin-1 engagement (Good-
ridge et al., 2011).
CLEC-2 and DNGR-1 (also known as CLEC9A) are two addi-
tional hemITAM-bearing receptors in the NK cell CLR subgroup
(Table 1). They resemble Dectin-1 and can signal via Syk but it is
unclear whether they bind PAMPs and act as PRRs. Although
CLEC-2 has been reported to bind HIV-1 (Chaipan et al.,
2006), it is best known as a platelet receptor that promotes coag-
ulation (Suzuki-Inoue et al., 2006). CLEC-2 is the target of the
platelet-activating snake venom toxin, rhodocytin, but also
possesses a physiological endogenous ligand, podoplanin,
that is involved in platelet aggregation, lymphatic vessel forma-
tion, and tumor metastasis (Kato et al., 2008; Suzuki-Inoue
et al., 2007). CLEC-2 is additionally expressed in B cells, NK
cells, and myeloid cells, but whether it has activatory function
in these cell types is unclear (unpublished observations).
DNGR-1 is highly restricted to DCs in both mouse and human
(Caminschi et al., 2008; Huysamen et al., 2008; Sancho et al.,
2008) and it is also unclear whether it acts as an activatory
receptor (unpublished observations). Notably, PAMPs for
DNGR-1 have not been reported but the receptor binds to an
unidentified ubiquitous intracellular ligand that is sequestered
in living cells and exposed upon cell death (Sancho et al.,
2009). DNGR-1 signaling via the hemITAM-Syk pathway is
important for priming CTL against antigens borne by dead cells
(Sancho et al., 2009). Therefore DNGR-1 may play a role in
adaptive immunity to infections that induce cell death even if it
does not act as a PRR.
SIGNR3 (CD209d), a mouse CLR that recognizes
Mycobacterium tuberculosis and its mannosylated lipoarabino-
mannan (ManLAM) component, also appears to signal via
a hemITAM-Syk pathway that results in induction of proinflam-
matory cytokines in mouse macrophages (Tanne et al., 2009).
Therefore, mouse SIGNR3 might constitute an additional
Table 1. Mouse and Human CLRs Mentioned in This Review
Common Namesa
Official Gene
Symbolb
Cytoplasmic
Signaling Motifc
Proximal
Signalingc Ligand Specificity Ligand Origin
mannose receptor,
CD206, CLEC13D
MRC1 (Hs),
Mrc1 (Mm)
? ? high mannose,
fucose
M. tuberculosis, M. kansasii,
F. tularensis, K. pneumoniae,
S. pneumoniae, HIV-1,
dengue virus, C. albicans,
C. neoformans, P. carinii,
Leishmania spp.
langerin, CD207,
CLEC4K
CD207 (Hs),
Cd207 (Mm)
? ? mannose, fucose,
N-acetyl-glucosamine,
b-glucan
HIV, Mycobacterium leprae,
Candida spp.,
Saccharomyces spp.,
Malassezia furfur
DEC-205, CD205,
CLEC13B
LY75 (Hs),
Ly75 (Mm)
? ? ND HIV, Y. pestis, endogenous
(dead cells)
DC-SIGN,
CLEC4L (Hs)
CD209 (Hs) ? Raf1 high mannose
and fucose
HIV, measles virus, SARS,
dengue virus, filoviruses,
CMV, Mycobacterium spp.,
C. albicans, Leishmania spp.,
S. mansonii egg antigen
Dectin-1, CLEC7A CLEC7A (Hs),
Clec7a (Mm)
hemITAM Syk, Raf1 b-1,3 glucans fungi, mycobacteria
DNGR-1, CLEC9A CLEC9A (Hs),
Clec9a (Mm)
hemITAM Syk ND endogenous (dead cells)
CLEC-2, CLEC1B CLEC1B (Hs),
Clec1b (Mm)
hemITAM Syk ND endogenous (podoplanin),
rhodocytin (snake venom),
HIV
SIGNR3 (Mm) Cd209d hemITAM Syk high mannose
and fucose
Mycobacterium tuberculosis
Dectin-2, CLEC6A,
CLEC4N
CLEC6A (Hs),
Clec4n (Mm)
ITAM
(adaptor FcRg chain)
Syk high mannose,
a-mannans
C. albicans, S. cerevisiae,
M. tuberculosis,
P. brasiliensis,
H. capsulatum, M. audouinii,
T. rubrum, C. neoformans,
house dust mite allergens
Mincle, CLEC4E CLEC4E (Hs),
Clec4e (Mm)
ITAM
(adaptor FcRg chain)
Syk a-mannose,
glycolipids, SAP130
(endogenous)
C. albicans,
Malasezzia spp.,
M. tuberculosis,
dead cells
MDL-1, CLEC5A CLEC5A (Hs),
Clec5a (Mm)
ITAM
(adaptor DAP12)
Syk? ND dengue virus
BDCA-2, CD303,
CLEC4C (Hs)2
CLEC4C (Hs) ITAM
(adaptor FcRg chain)
Syk mannose, fucose ND
mDCAR,
CLEC4B1 (Mm)
Clec4b1 (Mm) ITAM
(adaptor FcRg chain)
Syk? ND ND
mDCAR1,
CLEC4B2 (Mm)
Clec4b2 (Mm) ITAM?
(adaptor FcRg chain)?
Syk? ND ND
DCIR, CLEC4A CLEC4A (Hs),
Clec4a2 (Mm)
ITIM SHP-1, SHP-2 mannose, fucose HIV-1
macrophage antigen H,
CLEC12B
CLEC12B (Hs),
Clec12b (Mm)
ITIM SHP-1, SHP-2 ND ND
MICL, DCAL-2,
CLEC12A
CLEC12A (Hs),
Clec12a (Mm)
ITIM SHP-1, SHP-2 ND ND
Abbreviations: Hs, Homo sapiens; Mm, Mus musculus; ND, not determined. Table compiled from the references given in the main text.
aWhere only one species is shown, a direct ortholog does not exist in the other. See text for details.
b As per NCBI Gene database.
cCytoplasmic signaling motif and proximal signaling refer to the potential of a given CLR to signal to induce/modulate gene expression. Signals for
other CLR functions (e.g., endocytosis) are not indicated. Question mark denotes unknown or speculative attribution.
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Figure 2. Dectin-1 Signaling Pathways as a Paradigm for
Syk-Coupled CLRs
Syk-dependent and -independent signaling by Dectin-1 in response to
engagement by agonist ligands. Large multimeric b-glucan-containing parti-
cles trigger Dectin-1 possibly by promoting or stabilizing dimer formation,
preventing receptor internalization, as well as allowing exclusion of phos-
phatases. These events favor phosphorylation of the hemITAM motifs by Src
family kinases and allow for stable recruitment and activation of Syk kinase.
Syk acts as a node in the subsequent activation of NF-kB, MAP kinase, and
NFAT pathways, which together regulate expression of many innate response
genes. Syk additionally regulates the production of reactive oxygen species,
which can contribute, among others, to the activation of the NLRP3 in-
flammasome. A Syk-independent pathwaymediated by Raf1 regulates activity
of NF-kB p65. See text for details.
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However, the other six mouse SIGNR receptors do not couple
to Syk (Tanne et al., 2009). Interestingly, SIGNR3 has been
argued to be the closest functional homolog of human
DC-SIGN on the basis of both phylogeny and ligand specificity
(Powlesland et al., 2006; Tanne et al., 2009). DC-SIGN is
a human CLR that recognizes mannose signatures present in
M. tuberculosis, Mycobacterium leprae, Candida albicans,
Leishmania spp., measles virus, and HIV-1 gp120, as well as
fucose-based Lewis antigens in Helicobacter pylori and
Schistosoma mansoni (Table 1; Appelmelk et al., 2003; Geijten-
beek and Gringhuis, 2009). In contrast to mouse SIGNR3,
human DC-SIGN does not signal via Syk despite possessing
an intracellular YxxL motif and does not serve as a myeloid
activatory receptor on its own (Gringhuis et al., 2007). However,
it can modulate signaling through other receptors as will be
discussed later.
ITAM Signaling
Much as Dectin-1 provides a paradigm for hemITAM signaling,
Dectin-2 typifies ITAM-coupled CLRs. Dectin-2, despite its654 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.name, is only 20% homologous to Dectin-1 and belongs to
a separate structural subgroup of CLRs (Ariizumi et al., 2000a).
Dectin-2 is a type II transmembrane CLR with a typical Ca2+-
dependent CRD that mediates binding to high-mannose struc-
tures (McGreal et al., 2006), including a-mannans present in
C. albicans cell walls (Saijo et al., 2010). Dectin-2 can also recog-
nize various other fungi including Paracoccoides brasiliensis,
Histoplasma capsulatum, and Cryptococcus neoformans
(McGreal et al., 2006; Sato et al., 2006) and is additionally
involved in the recognition of house dust mite allergens (Barrett
et al., 2009) and of S. mansoni egg extracts (Ritter et al., 2010).
As for Dectin-1, Dectin-2 may possess an unknown endogenous
ligand (Aragane et al., 2003). Although it was originally described
a Langerhans cells marker (Ariizumi et al., 2000a; Bonkobara
et al., 2001), further studies have demonstrated that Dectin-2 is
generally expressed in myeloid cells, including macrophages
and monocytes and various subtypes of DCs (Robinson et al.,
2009; Taylor et al., 2005). Dectin-2 can associate with the
ITAM-bearing Fc receptor g (FcRg) chain and stimulation of
Dectin-2 causes phosphorylation of the tyrosines in the FcRg
ITAM leading to Syk recruitment (Barrett et al., 2009; Robinson
et al., 2009; Sato et al., 2006).
Mincle (macrophage inducible C-type lectin) also associates
with FcRg chain and ligand binding causes phosphorylation of
the FcRg chain ITAM and recruitment of Syk (Yamasaki et al.,
2008). Mincle is expressed predominantly in macrophages and,
like Dectin-2, recognizes a-mannose residues via a Ca2+-depen-
dent CRD interaction (Table 1). It has been shown to bind to fungi
including C. albicans and Malasezzia spp. and to trehalose-6,
60-dimycolate present in Mycobacterium tuberculosis (Bugarcic
et al., 2008; Ishikawa et al., 2009; Wells et al., 2008; Yamasaki
et al., 2009).Mincle additionally recognizes the endogenous ribo-
nucleoprotein SAP130,which is exposedbydeadcells, but this is
independent of theCRD residues involved in bindinga-mannose,
arguing for two distinct binding sites (Yamasaki et al., 2008). The
Mincle-mediated response to dead cells triggers the infiltration of
neutrophils to areas of tissue damage and may be primarily
involved in tissue repair rather than immunity (Yamasaki et al.,
2008). In contrast, the fungal-binding activity of Mincle is likely
to be involved in host defense (see below).
Other ITAM-coupled CLRs include MDL-1 (myeloid DAP12-
associating lectin-1, also known as CLEC5A), a CLR expressed
in monocytes, macrophages, and osteoclasts. MDL-1 associ-
ates with the ITAM-bearing adaptor DAP12, as well as with
DAP10, which leads to PI3 kinase activation (Bakker et al.,
1999; Chen et al., 2008; Inui et al., 2009). Recently, it has been
shown that MDL-1 binds dengue virus and induces production
of TNF-a in macrophages but whether this occurs by signaling
through Syk has yet to be formally demonstrated (Chen et al.,
2008). Finally, mDCAR and mDCAR-1 in mouse may constitute
additional Syk-coupled myeloid activatory CLRs that associate
with FcRg although their ligands and function at present remains
unknown (Kaden et al., 2009; Kanazawa et al., 2003). There is no
direct ortholog of mDCAR or mDCAR-1 in human but they are
closely related to human BDCA-2 (blood dendritic cell antigen
2), which is expressed in plasmacytoid DCs (Dzionek et al.,
2000, 2001). BDCA-2 associates with FcRg and signals through
Syk but, paradoxically, appears to act as an inhibitory rather than
activatory receptor (discussed below).
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Syk function in CLR signaling is analogous to that in B cell
receptor signaling and involves many of the same players,
including BLNK, SLP-76, Vav, Rac, and PLCg (Mo´csai et al.,
2010). The key to the ability of some Syk-coupled CLRs to func-
tion as PRRs lies in their capacity to activate NF-kB downstream
of Syk. Canonical NF-kB activation by Dectin-1 and Dectin-2
requires the adaptor protein CARD9 (Gross et al., 2006; Robin-
son et al., 2009). This adaptor has been shown to be rapidly
recruited to phagosomes containing ingested fungal particles
(Goodridge et al., 2009) although it can presumably also be
triggered at the plasmamembrane because Dectin-1 internaliza-
tion is associated with termination of signaling (Hernanz-Falco´n
et al., 2009; Rosas et al., 2008). Whether at the cell surface or
in endosomes, CARD9 then recruits Bcl-10 and Malt-1 and
activates the IKK complex, which phosphorylates IkB and
promotes its degradation, allowing the NF-kB family members
to translocate to the nucleus (Figure 2; Gross et al., 2006). It is
not entirely clear how Syk and CARD9 control IKK activation,
one idea being that they act sequentially (i.e., Syk activates
CARD9), another that Syk acts by phosphorylating the IKK
complex while CARD9 regulates ubiquitination of the NEMO
regulatory subunit (Bi et al., 2010). Notably, not all subunits of
NF-kB are equally activated by both Dectins or by the individual
members of the CARD9:Bcl-10:Malt-1 complex. For example,
c-Rel is especially dependent on Malt-1 and is the only NF-kB
subunit activated by Dectin-2 crosslinking in human DCs
whereas Dectin-1 triggering in the same cells activates all
NF-kB subunits (Gringhuis et al., 2011). In addition, unusually
for a PRR, Dectin-1-Syk signaling also leads to activation of
the noncanonical NIK-dependent and CARD9-independent
NF-kB pathway that results in activation of RelB (Figure 2;
Gringhuis et al., 2009b).
Differential regulation of the Syk-NF-kB axis may explain why
distinct Syk-coupled CLRs vary in their ability to activate NF-kB
(unpublished observations). But the ability of a given CLR to
activate NF-kB also differs among myeloid cells, leading to
conflicting reports. For Dectin-1 signaling, NF-kB activation
correlates with the amounts of CARD9 expressed by each
myeloid cell type, but it has also been argued that inhibitors
of the pathway may be expressed in macrophages (Goodridge
et al., 2009). Such cell-specific regulation of the Syk-CARD9
pathway could explain why in some cells CLR signaling is suffi-
cient for activation of a transcriptional response whereas in
other cell types it works only in synergy with signals from other
receptors (see below).
Signaling through Dectin-1 or Dectin-2 activates transcription
factors besides NF-kB. It results in activation of MAP and
PI3 kinase pathways (LeibundGut-Landmann et al., 2007;
Robinson et al., 2009; Shah et al., 2009; Slack et al., 2007) and
in PLCg-dependent Ca2+ elevation, leading to calcineurin-
dependent dephosphorylation of NFAT and its nuclear translo-
cation (Figure 2; Goodridge et al., 2007; Greenblatt et al., 2010;
Tassi et al., 2009; Xu et al., 2009). The latter is an important differ-
ence from TLR signaling, which does not appreciably lead to
NFAT activation, and underlies a unique signature of Dectin
signaling, including the induction of high amounts of IL-2 and
IL-10 in DCs and cyclooxygenase-2 (COX-2) and PGE2 in
macrophages (Goodridge et al., 2007).The consequences of Dectin-Syk activation for host defense
extend beyond the activation of transcription. Syk activation
has pleiotropic effects in myeloid cell biology including differen-
tiation, cytoskeletal rearrangements, proliferation, and survival
(Mo´csai et al., 2010). One obvious property of many CLRs is
the ability to mediate ligand internalization through endocytosis
or phagocytosis. This is a divergent property from TLRs, which,
by and large, are not considered to be endocytic receptors. Syk
contributes to phagocytosis of fungal particles by DCs although
not macrophages (Herre et al., 2004; Rogers et al., 2005; Under-
hill et al., 2005) and may affect the maturation of endosomes or
phagosomes containing dead cells downstream of DNGR-1
engagement (unpublished observations). In addition to internal-
ization, Syk can control events within phagosomes. Activation of
Dectins results in Syk-dependent production of reactive oxygen
species (ROS) in myeloid cells (Figure 2; Gross et al., 2009; Ritter
et al., 2010; Underhill et al., 2005). ROS contributes to microbici-
dal activity within the phagosome (Steele et al., 2003) but
additionally can act as a point of regulation for IL-1b production.
IL-1b is transcriptionally regulated by NF-kB and posttransla-
tionally regulated by the inflammasome (Martinon et al., 2009).
Whereas the Syk-CARD9 pathway activates the synthesis of
pro-IL-1b, Syk additionally can activate the NLRP3 inflamma-
some in a ROS-dependent manner, resulting in proteolytic
processing of IL-1b by caspase-1 (Figure 2; Gross et al., 2009).
Notably, IL-1b has a crucial role in antifungal immunity (Vonk
et al., 2006). Some studies have suggested that caspase-1 is
dispensable for resistance to candidiasis (Mencacci et al.,
2000) and that production of IL-1b by human monocytes stimu-
lated with fungi stimulation is independent of the inflammasome
(van de Veerdonk et al., 2009a). However, in other studies
NLRP3-deficient mice were shown to be highly susceptible to
fungal infection (Gross et al., 2009; Guarda et al., 2011). The
latter suggest that, by regulating IL-1b processing, Dectin-Syk
signaling could control host resistance to infection indepen-
dently of any role in gene induction. In contrast, in Schistosoma
infection, Dectin-2-Syk-NLRP3 signaling does not reduce para-
site burden but, rather, contributes to immunopathology (Ritter
et al., 2010). Finally, Dectin-2 activation in DCs by allergens
from house dust mite or mold leads to generation of cysteinyl
leukotrienes, proinflammatory lipids that contribute to allergy
(Barrett et al., 2009).
ITIM Signaling
In contrast to the CLRs discussed above, others possess an
inhibitory ITIM motif and have been proposed to raise the
threshold for myeloid cell activation (Geijtenbeek and Gringhuis,
2009; Robinson et al., 2006). ITIM-bearing CLRs include DCIR
(DC-inhibitory receptor), which is expressed in human mono-
cytes, macrophages, B cells, and DCs. When crosslinked by
monoclonal antibodies, DCIR inhibits TLR8-mediated induction
of IL-12 and TNF-a by myeloid DCs and TLR9-induced IFN-a
production by plasmacytoid DCs (Meyer-Wentrup et al., 2008,
2009). In mouse, there are four DCIR homologs (mDCIR and
mDCIR2-4) but only mDCIR and mDCIR2 (also known as 33D1)
possess an ITIM (Kaden et al., 2009). Their function is not known
but mDCIR-deficient mice develop autoimmunity and marked
expansion of the DC compartment (Fujikado et al., 2008).
Another ITIM-containing CLR, MICL (myeloid inhibitory C-typeImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 655
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cytes, macrophages, and DCs and its ligation has been shown
to inhibit IL-12 responses to LPS and zymosan (Chen et al.,
2006; Marshall et al., 2004). It is unclear how ITIM-bearing
CLRs inhibit TLR signaling, which does not involve a phosphotyr-
osine cascade and, therefore, the above studies may reflect an
indirect effect of ITIM signals, for example on the activity of
Syk-coupled receptors that synergize with TLR signaling (see
below). Alternatively, inhibition of TLR responses could result
from interference with PI3 kinase pathways by the inositol phos-
phatase SHIP.
Negative regulation of cell activation can paradoxically also
ensue from engagement of ITAM-bearing receptors (Hamerman
et al., 2009). For example, BDCA-2 signals through Syk, BLNK,
and PLCg2 in plasmacytoid DCs to downmodulate the produc-
tion of type I IFN and the secretion of TRAIL induced by TLR
agonists (Cao et al., 2007; Riboldi et al., 2009; Ro¨ck et al.,
2007). It is not known whether BDCA-2 acts only to dampen
TLR responses or whether it can trigger plasmacytoid DC
function in isolation. Nevertheless, the dual role of ITAM signaling
in cell activation and cell inhibition indicates an unexpected
degree of complexity in the regulation of the activity of CLRs
that use phosphotyrosine-based signaling motifs.
Tyrosine-Independent CLR Signaling
CLRs can also engage nontyrosine-based signaling pathways
that impact innate and adaptive immune responses (Geijtenbeek
and Gringhuis, 2009). However, unlike ITAM or hemITAM
signaling, these pathways have not been shown to be sufficient
for myeloid function. Rather, they act to regulate and fine tune
cell activation induced by the same or other PRRs (Geijtenbeek
and Gringhuis, 2009).
Raf1 Signaling
Some CLRs have been shown to activate the serine/threonine
kinase Raf1, better known for its role in Ras signaling. This
was first shown for DC-SIGN in response to engagement by
ManLAM, an M. tuberculosis-derived ligand for DC-SIGN that
modifies the response of human DCs to LPS (Geijtenbeek
et al., 2003). The mechanism leading to the activation of Raf1
upon DC-SIGN engagement by mannose-rich ligands does not
require the YxxL motif present in the intracellular tail of DC-SIGN
but involves a complex of LSP1, KSR, and CNK proteins, which
is constitutively associated with DC-SIGN, as well as the
proteins LARG and RhoA, which are recruited to the complex
upon ManLAM binding (Gringhuis et al., 2007, 2009a). Raf1
signaling does not activate DCs but modulates TLR-mediated
NF-kB activation by directly or indirectly leading to phosphoryla-
tion of the NF-kB p65 subunit on Ser276, which permits subse-
quent acetylation. The latter results in prolonged and increased
transcription of the genes encoding IL-10 and a few other cyto-
kines (Gringhuis et al., 2007, 2009a). Interestingly, fucose-based
ligands for DC-SIGN do not lead to Raf1 signaling even though
they can still potentiate TLR-induced IL-10 production in human
DCs via a pathway requiring LSP1 (Gringhuis et al., 2009a).
Like human DC-SIGN, mouse SIGNR3 also appears to signal
via the Raf1 pathway, in addition to utilizing the hemITAM-Syk
pathway (Tanne et al., 2009). Similarly, Dectin-1 has been shown
to also signal via Raf1 in human DCs (Figure 2). This pathway656 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.operates independently of Syk but converges at the level of
NF-kB (Figure 2; Gringhuis et al., 2009b). Whereas Syk signaling
results in activation of the canonical and noncanonical NF-kB
pathways, Raf1 activation results in phosphorylation and subse-
quent acetylation of NF-kB p65, as in DC-SIGN signaling
(Figure 2; Gringhuis et al., 2009b). Acetylated p65 can become
transcriptionally active in partnership with p50 or it can generate
RelB-p65 inactive dimers that do not bind to DNA (Gringhuis
et al., 2009b). Overall, Raf1 activation by Dectin-1 enhances
the expression of some Syk-dependent cytokines in human
DCs, including IL-10, IL-12, IL-6, and IL-1b, but negatively
regulates the production of IL-23 (Gringhuis et al., 2009b). This
is associated with an increase in the IL-12/IL-23 ratio and has
been implicated in the induction of Th1 cell responses by DCs
activated through Dectin-1 (Gringhuis et al., 2009b).
Role of Syk-Coupled CLRs in Host Defense
The ligands for ITIM-bearing CLRs are not presently known and
it is unclear to what extent these inhibitory receptors impact
the outcome of infection. However, many of the Syk-coupled
receptors discussed in this review recognize pathogens and
probably evolved as activatory receptors in response to infec-
tious pressure. Their role in host defense can sometimes be
difficult to assess because of redundancy among PRRs and
evolutionary pressure on organisms to alter or subvert PAMP
recognition. For example, b-glucans are sequestered in the inner
layer of fungal cell walls: C. albicans, an opportunistic pathogen
in humans, exposes b-glucans at the budding points only during
yeast cell division (Gantner et al., 2005). However, upon transi-
tion of the fungus from the yeast to the hyphal form, budding
ceases and hyphae are effectively devoid of exposed b-glucan
(Gantner et al., 2005). Despite the rarity of b-glucan exposure
during the fungal life cycle, Dectin-1 plays a role in restricting
C. albicans infection. Mice deficient in Dectin-1 display
increased mortality and higher fungal burdens upon i.v. infection
with C. albicans, although the penetrance of this effect is
variable, having been seen in one study but not in another (Saijo
et al., 2007; Taylor et al., 2007). In a different model of mixed
oropharyngeal and systemic infection, Dectin-1-deficient mice
showed increased systemic C. albicans dissemination from
the site of infection and a slight augmentation in mortality (Hise
et al., 2009). The variable Dectin-1 dependence in different
studies is probably due to differences in the strain of
C. albicans and in the route used for infection, superimposed
on the compensatory effects of other PRRs. The latter includes
Dectin-2; mice deficient in that CLR have also been reported
to display higher mortality and elevated fungal burdens after
i.v. infection with three strains of C. albicans (Saijo et al., 2010).
Mincle may also compensate for deficiency in either Dectin-1
or Dectin-2 as, in one study, Mincle-deficient mice showed
higher kidney fungal burden early after infection with
C. albicans i.v. (Wells et al., 2008). However, Dectin-1-, Dectin-
2-, or Mincle-deficient mice resist their own fungal commensals
and are not profoundly susceptible to fungal infections as a
whole. This has been noted by testing models other than
C. albicans: Dectin-1-deficient mice show transient increases
in lung fungal burden when infected with Pneumocystis carinii
cysts i.n. yet are able to clear the infection longterm, much like
wild-type mice (Saijo et al., 2007). Dectin-2-deficient mice are
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neoformans (Saijo et al., 2010).
Dectin-1 and Dectin-2 control antifungal adaptive immunity
(see below) but also clearly regulate innate resistance to fungi.
Thus, Dectin-1-deficient mice infected intratracheally with
Aspergillus fumigatus conidia, another human opportunistic
pathogen, show increased mortality very early after infection
(Werner et al., 2009). Similarly, even when adaptive immunity
to P. carinii is compromised by cortisone treatment, Dectin-1
deficiency still results in higher fungal burden in the lung (Saijo
et al., 2007). A dramatic example of loss of innate resistance to
fungal infection is the phenotype of CARD9-deficient mice that
succumb rapidly to disseminated candidiasis when infected
i.v. with C. albicans (Gross et al., 2006). Similarly, mice with
defective NFAT activation, induced by either systemic treatment
with a calcineurin inhibitor or genetic deletion of calcineurin in
neutrophils and other myeloid cells, are highly susceptible to
disseminated candidiasis (Greenblatt et al., 2010). Thus, it
appears that interference with downstream targets of CLR
signaling gives more profound impairment of innate resistance
to fungal infection than ablation of single receptors. This may
be expected from CLR redundancy but raises the question of
specificity. CARD9, for example, has also been implicated
downstream of NOD protein, TLR, and RIG-I-like receptor
signaling (Hara et al., 2007; Hsu et al., 2007; Poeck et al., 2010).
Mice deficient in Syk-coupled CLR have yet to be tested
systematically for impairment in immunity to nonfungal organ-
isms. Mycobacterial species can be recognized by Dectin-1,
yet Dectin-1-deficient mice do not show altered resistance to
lung infection with M. tuberculosis (Marakalala et al., 2011).
In contrast, CARD9-deficient mice are susceptible to experi-
mental infection with the same organism (Dorhoi et al., 2010).
This discrepancy could reflect the activity of Mincle in recog-
nizing trehalose-6,60-dimycolate, although the ability of the
receptor to directly bind mycobacteria and the susceptibility of
Mincle-deficient mice to mycobacterial infection has not yet
been reported. Notably, SIGNR3-deficient mice are also more
susceptible to infection with M. tuberculosis although SIGNR3
has not yet been formally shown to signal through CARD9
(Tanne et al., 2009).
Finally, Syk-coupled CLR signaling might in some cases
adversely affect the outcome of infection by favoring immunopa-
thology. This appears to be the case for MDL-1 in infection with
dengue virus, which elicits TNF-a production by macrophages
(presumably via Syk) and thereby appears to contribute to the
hemorrhagic and plasma leakage syndrome associated with
the disease (Chen et al., 2008). Whether MDL-1 has evolved to
recognize dengue virus or is, instead, targeted by the virus is
unclear.
Crosstalk between CLRs and Other Innate Receptors
Pathogens generally contain multiple PAMPs and therefore
engagemultiple PRRs together or sequentially. Thus, the immune
response to any one pathogen involves a multitude of PRRs, as
well asother innate receptors suchasones involved in recognition
of altered self or cell death. CLR collaboration with other recep-
tors is well established. In fact, the innate role of Dectin-1was first
ascribed to its ability to collaborate with TLR2 in promoting
proinflammatory cytokines such as TNF-a production in macro-phages stimulated with zymosan (Brown et al., 2003; Gantner
et al., 2003). However, it is worth definingwhat ismeant by collab-
oration. In the case of Dectin-1-TLR2 collaboration in macro-
phages, this is likely to have been due to synergistic activation
of transcription modules mediated by signaling through Dectin-
1-Syk and TLR2-MyD88 pathways (Dennehy et al., 2008). In
neutrophils, this same synergy induces an anti-inflammatory
signature characterized by production of IL-10 rather than
TNF-a, arguing for cell-specific outcomes (Zhang et al., 2009).
Nevertheless, in both cases CLR signalingmay be seen as acting
primarily in a quantitative sense to shift the dose response to a
givenTLRagonist andvice versa.Adistinct senseof collaboration
is that in which a receptor has a qualitative effect. An example
from the TLR field is CD14, which, among other roles, can signal
to promote Ca2+-dependent NFAT activation and qualitatively
alters the response to TLR4 triggering by LPS (Zanoni et al.,
2009). However, CD14 by itself does not activate NF-kB and is
not considered to be a PRR. Relevant to the present discussion,
in some instances, Syk-coupled CLRs activate NFAT but not NF-
kB andmay therefore act primarily like CD14 (unpublished obser-
vations).Similarly,asdiscussedabove,DC-SIGNacts inaqualita-
tive sense as a modulator of NF-kB activation by other PRRs. An
additional sense of collaboration is that in which the response
through one receptor allows the action of another. The purported
ability of Syk-coupled CLRs to induce ROS in the context of
C. albicans infection and thereby promote NLRP3 activation and
pro-IL-1b processing may be considered a form of collaboration
that can result in innate resistance to infection. A distinct example
is where CLR signaling affects phagosomal fate and controls
accessibility of cargo to other PRRs. Syk-coupled receptors
(possibly CLRs?) have been implicated in the uptake of Candida
glabrata and/or routing of phagosomes to a compartment where
Candida RNA can then be sampled by TLR7 (Bourgeois et al.,
2011). This leads to IFN-a and/or IFN-b induction, which impairs
resistance to Candida spp. (Bourgeois et al., 2011; Guarda
et al., 2011), so this particular form of collaboration is actually
detrimental to the host. Finally, when dealing with particulate
stimuli such as fungi andbacteria, collaborationbetweendifferent
receptors needs to be assessedwith cautionbecause aparticular
receptor might simply increase particle binding to the phagocyte,
thereby allowing the subsequent recruitment of signaling recep-
tors. This makes it especially difficult to interpret many studies
where blocking antibodies for a given receptor and/or genetically
deficient cells are used to demonstrate defects in the inflamma-
tory response to fungal or bacterial particles.
With these considerations in mind, many innate immune
receptors can be shown to influence resistance to fungal
infection in mouse studies. For example, the C. albicans cell
wall has ligands for many receptors on myeloid cells (Figure 3).
N-linked mannans are preferentially recognized by mannose
receptor, DC-SIGN, and SIGNR1 in DCs and macrophages
(Cambi et al., 2008; Taylor et al., 2004). In contrast, Dectin-2
recognizes a-mannans and TLR2 can detect phospholipo-
mannan-containing molecules (Jouault et al., 2003; Saijo et al.,
2010). Additionally, sensing of O-linked mannans has been
attributed to TLR4 (Netea et al., 2006). b-glucans are ligands
for Dectin-1, complement receptor 3 (CR3), and the scavenger
receptors CD36 and SCARF1 (Forsyth et al., 1998; Gantner
et al., 2005; Means et al., 2009). Enhanced resistance and lowerImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 657
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Figure 3. Innate Recognition of Fungal Cell
Walls by Receptors Expressed on DCs and
Macrophages
Multiple myeloid innate immune receptors have
been shown to recognize cell wall components
of C. albicans. Signals emanating directly or
indirectly from these receptors are responsible
for initiating and modulating immunity to the
organism. They act together with signals from
receptors (not depicted) that recognize additional
components of the cell wall or the fungus body
(e.g., RNA) or fungus-bound opsonins (e.g., anti-
bodies, complement). See text for details.
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deficient mice infected with C. albicans (Romani et al., 2004).
This is not to be confused with mice deficient in FcRg chain,
which mediates signals by Dectin-2 and is therefore presumably
necessary for resistance to C. albicans (Saijo et al., 2010).
The contribution of TLRs has also been addressed in vivo. Two
studies have shown that TLR2-deficient mice are more resistant
to C. albicans infection, suggesting an inhibitory role for this
receptor during fungal recognition, perhaps through induction
of IL-10-producing regulatory T cells that suppress antifungal
defense (Bellocchio et al., 2004; Netea et al., 2004). In contrast,
TLR2 plays a protective role in themodel of mixed oropharyngeal
and systemic candidiasis, controlling fungal dissemination and
contributing to inflammasome activation (Hise et al., 2009).
TLR4 or TLR9 deficiency does not impair survival to systemic
candidiasis, suggesting that these receptors are redundant (Bel-
locchio et al., 2004). In contrast to single TLR deficiency, lack of
the adaptor MyD88 renders mice highly susceptible to dissemi-
nated candidiasis (Bellocchio et al., 2004; Villamo´n et al., 2004),
but this effect may be attributable to signaling via IL-1R, as
indicated by the fact that IL-1R-deficient mice are equally
susceptible to systemic infection (Bellocchio et al., 2004). Inter-
estingly, the negative regulator of TLR and IL-1R signaling TIR8
(Toll IL-1R8) is nonredundant in anti-Candida defense, as shown
by the fact that TIR8-deficient mice succumb to disseminated
candidiasis (Bozza et al., 2008). In sum, these results indicate
that fine regulation of CLR and TLR-IL-1R signaling is necessary
for effective clearance of fungal pathogens.
Induction of Adaptive Immunity by CLR Signaling via Syk
PRRs that signal through NF-kB, such as TLRs, promote activa-
tion of DCs, rendering them competent to activate adaptive
immunity. Syk-CARD9-coupled CLRs expressed in DCs might
therefore be expected to similarly couple pathogen sensing to658 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.adaptive immunity. In the case of Dec-
tin-1, demonstration of sufficiency
involved moving away from fungal parti-
cles and finding a specific agonist that
does not engage additional receptors.
Curdlan is a b-(1,3)-glucan polymer
produced by the bacterium Alcaligenes
faecalis that acts as a selective Dectin-1
agonist (LeibundGut-Landmann et al.,
2007; Yoshitomi et al., 2005). Curdlan is
sufficient to fully activate DCs, even inthe absence of the two TLR adaptors MyD88 and TRIF (Lei-
bundGut-Landmann et al., 2007). Human or mouse DCs acti-
vated with curdlan are able to promote T helper 1 (Th1) and
Th17 cell differentiation of naive CD4+ T cells (Gringhuis et al.,
2009b; LeibundGut-Landmann et al., 2007) and induce the
conversion of Foxp3+RORgt+ regulatory T cells into IL-17-
producing Foxp3+ cells in vitro (Osorio et al., 2008). When
curdlan is used as an adjuvant in vivo, it promotes both Th1
and Th17 cell responses unlike TLR agonists, which predomi-
nantly induce Th1 cell differentiation (Joffre et al., 2010; Lei-
bundGut-Landmann et al., 2007). Adjuvancy is not confined to
the induction of CD4+ T cell responses as indicated by the fact
that curdlan additionally promotes antibody responses and cyto-
toxic T lymphocyte (CTL) crosspriming (LeibundGut-Landmann
et al., 2007, 2008). In addition to inducing Th17 cells, Dectin-1
can also directly trigger the production of IL-17 by a subset of
gd T cells (Martin et al., 2009). The elicitation of Th17 cell-type
responses by Dectin-1 is an essential feature of antifungal
immunity (see below).
The issue of sufficiency in inducing adaptive immunity has not
been thoroughly explored for other Syk-coupled CLRs.
However, the adjuvanticity of trehalose-6-60-dimycolate and its
synthetic analog requires Syk and CARD9 signaling, especially
for Th17 cell responses (Werninghaus et al., 2009). Because
Mincle was recently reported as the receptor for trehalose-6-
60-dimycolate (Ishikawa et al., 2009; Schoenen et al., 2010),
these results imply that selective triggering of Mincle might be
sufficient to promote adaptive immunity. In addition, the demon-
strable ability of Dectin-2 and MDL-1 to activate NF-kB in DCs
suggests that signals through these receptors might also suffice
to induce adaptive immunity although this remains to be formally
proven and could differ between mouse and human DCs (Chen
et al., 2008; Gringhuis et al., 2011; Robinson et al., 2009; Saijo
et al., 2010).
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acquired immunity is to examine necessity rather than suffi-
ciency. This does not formally prove that the PRR alone can
bridge innate and adaptive immunity but does reveal points of
lack of redundancy, which indicate a key role for the receptor
in question in the regulation of T cell and B cell responses in
the model chosen for analysis. This approach has been espe-
cially productive; it has revealed a nonredundant role for Syk-
coupled CLRs in the induction of Th17 cell responses to fungal
infection. Indeed, Th17 cell responses to C. albicans are easily
detected in infected mice, alongside Th1 cell responses (Lei-
bundGut-Landmann et al., 2007). When CARD9-deficient mice
were infected with a very low dose of organism (to circumvent
the lethality caused by loss of innate resistance), the impact of
CARD9 on adaptive immunity became evident: Th17 cells
specific for C. albicans were absent whereas Th1 cell responses
were largely preserved (LeibundGut-Landmann et al., 2007). In
the same study, it was shown that Th17 cell responses to
C. albicans were not lost in Dectin-1-deficient infected mice
(LeibundGut-Landmann et al., 2007), which was later shown to
be due to the compensatory effects of Dectin-2 (Robinson
et al., 2009). Indeed, Dectin-2 rather than Dectin-1 appears to
be the predominant CLR involved in coupling innate recognition
ofCandida albicans to the induction of Th17 cell responses (Rob-
inson et al., 2009; Saijo et al., 2010). Recent data have confirmed
that Dectin-1 and Dectin-2 signaling in human DCs also favors
Th17 cell responses and showed that selective activation of
c-Rel by Dectin-2 controls IL-1b and IL-23 p19, two cytokines
involved in Th17 cell polarization (Gringhuis et al., 2011). Thus,
unlike Dectin-1 signaling, which activates DCs to induce both
Th1 and Th17 cell responses, Dectin-2 signaling predominantly
favors induction of the latter, although in human DCs this may
require signals from additional receptors (Gringhuis et al.,
2011). The fact that Dectin-2 is involved in Th17 cell defense to
C. albicans in mouse and human distinguishes it from the
mannose receptor, which is reported to coordinate human
Th17 cell responses to Candida (van de Veerdonk et al.,
2009b) but has no impact in host defense during fungal infection
in mice (Lee et al., 2003). Interestingly, a recent report indicates
that Dectin-2-mediated induction of cysteinyl leukotrienes can
also lead to the Th2 cell-biased response associated with house
dust mite allergic disease (Barrett et al., 2011). In sum, CLR
signaling through Syk can induce Th1 and Th17 cell-type
immunity, is nonredundant for Th17 cell responses to fungal
infection, and may additionally regulate Th2 cell responses to
some allergens.
CLRs in Human Immunity to Infection
Why the connection between PRRs specialized in fungal recog-
nition and the induction of Th17 cell responses? Intriguingly,
a role for type 17 responses in protection from fungal infections
has recently emerged. Despite a report that Th17 cell responses
promote pathology in an intragastricmodel of mouse candidiasis
(Zelante et al., 2007), mice deficient in IL-17RA or IL-17RC have
been reported to be susceptible to systemic and oropharyngeal
candidiasis (Conti et al., 2009; Ho et al., 2010; Huang et al.,
2004). Similarly, mice deficient in IL-23, IL-17A, and IL-17F are
also more susceptible to cutaneous and/or systemic
C. albicans infection (Kagami et al., 2010; Saijo et al., 2010)and both IL-17RA- and IL-17F- but not IL-17A-deficient mice
are more susceptible to gastric infection with the same organism
(De Luca et al., 2010). Mice deficient in IL-22 also display
impaired resistance to i.v. and/or intragastric C. albicans infec-
tion (De Luca et al., 2010). Thus, in manymousemodels of candi-
diasis, type 17 responses overall appear protective even though
the contribution of individual cytokines to resistance remains
a matter of debate.
A clearer picture of the protective role of Th17 cell responses
during fungal infections emerges from studies in humans.
Human memory CD4+ T cells specific for C. albicans have a
Th17 cell phenotype (Acosta-Rodriguez et al., 2007; Zhou
et al., 2008), and T cell immunodeficiency is commonly associ-
ated with chronic mucocutaneous candidiasis (CMC) as in the
case of HIV patients with low CD4+ T cell counts, who suffer
from oropharyngeal infections (‘‘oral thrush’’). Interestingly,
patients with mutations in STAT3 fail to generate Th17 cells
and suffer from chronic or recurrent CMC and S. aureus infec-
tions (de Beaucoudrey et al., 2008; Ma et al., 2008; Milner
et al., 2008). Similarly, autoimmune polyendocrinopathy
syndrome-I patients with a deficiency in AIRE display high titers
of neutralizing autoantibodies against IL-17A, IL-17F, and IL-22
and suffer from CMC (Kisand et al., 2010; Puel et al., 2010).
Finally, a recent study formally showed the role of type 17 immu-
nity in the control of mucosal Candida infection by identifying
mutations in IL-17RA or in IL-17F as genetic etiologies of familial
CMC (Puel et al., 2011).
Excitingly, a connection between the CLR pathway and
susceptibility to fungal infections in humans has recently been
reported. A premature stop mutation in Dectin-1 or a homozy-
gous point mutation in CARD9 have been found in two families
susceptible to CMC (Ferwerda et al., 2009; Glocker et al.,
2009). The CMC patients with Dectin-1 deficiency have a paucity
of IL-17-producing cells in peripheral blood and suffer from
vulvovaginal candidiasis and onychomycosis (fungal infection
in the nail beds) but not from systemic fungal infections (Fer-
werda et al., 2009). CARD9-deficient patients also display low
numbers of circulating Th17 cells but have more severe clinical
symptoms, with CMC but also invasive fungal infections
that can lead to death (Glocker et al., 2009). Themutation in Dec-
tin-1 was subsequently shown to represent a polymorphism and
has been associated with susceptibility to invasive Aspergillosis
and mucosal colonization with C. albicans after human stem cell
transplantation (Chai et al., 2011; Cunha et al., 2010; Plantinga
et al., 2009). In sum, evidence in humans strongly indicate that
signaling downstream of fungal-specific C-type lectin receptors
is an essential axis in the establishment of antifungal Th17 cell
responses, which in turn act as key mediators of protection
from fungal infection at mucocutaneous surfaces.
Conclusion
Myeloid CLRs constitute an eclectic group of innate immune
receptors with multiple functions in the initiation and regulation
of immune responses. They can act as endocytic receptors
that mediate the uptake of self-antigens and pathogens for either
destruction or antigen retrieval and presentation to T cells. In
addition, many CLRs signal to modulate myeloid cell activation
and thereby impact inflammation and the induction of adaptive
immune responses. Activatory myeloid CLRs tend to signalImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 659
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Reviewthrough Syk kinase, whereas inhibitory CLRs often recruit phos-
phatases. Some CLRs additionally or alternatively utilize RAF-1
kinase tomodulatemyeloid cell activation. Notably, Syk-coupled
myeloid CLRs and their associated signaling partners have
emerged as indispensable nodes for Th17 cell-type immunity
and resistance to fungal infections in both human and mouse.
This lack of redundancy in innate recognition pathways is unan-
ticipated and indicates that some myeloid CLRs may have
specifically been co-opted into host protection as key modules
to cover gaps left by the Toll-, RIG-I-, andNod-like receptor fami-
lies. Further research in this field may yet reveal new facets of
CLR function in immunity.
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